Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Emergent BioSolutions Stock a Buy?

TheMotleyFool

0 0

The stock of Emergent BioSolutions (NYSE: EBS) has been on fire of late. Year to date, shares are up by 56.6%, while the S&P 500 is down by 9.3%. What's behind Emergent's strong performance amid a highly volatile stock market and challenging economic conditions? The company has been involved in the race to develop a vaccine for COVID-19.

Specifically, Emergent signed several contract development and manufacturing agreements with other companies that are currently developing vaccines for the coronavirus. Emergent does have more than just its COVID-19 deals going on, though. With that in mind, let's dig into the company's business and find out whether Emergent can continue outperforming the market.